We discuss the case of a young patient presenting with euglycemic DKA. Say what? How common is this entity and what is the impact of a new class of diabetic medication? We answer these important questions and much more on this episode.
You can get CME credit for this episode here! Click here for CME Account Creation Instructions
In February, we discussed the results of the ADRENAL trial and implications for clinical practice. Since that time, another large trial and meta-analysis has...
In December 2019 a novel coronavirus (now named COVID-19) was identified as responsible for a cluster of pneumonia cases in Wuhan, China. As of...
Given the development of ED-ICUs and the ever increasing boarding of critically ill patients in the ED, extubation in the ED has become a...